Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer

Journal of International Medical Research

Volumn 41, Issue 4, 2013, Pages 984-992

  Liu, H ^a   Wu, J ^a   Xue, S ^a   Zhang, Q ^a   Ruan, Y ^a   Sun, X ^a   Xia, Sujie ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

2 m continuous wave laser; Bladder carcinoma; recurrence rate; transurethral resection of bladder tumour; TURBT

Indexed keywords

EPIRUBICIN; THULIUM;

ADULT; AGED; ARTICLE; BLADDER CATHETERIZATION; BLADDER IRRIGATION; BLADDER IRRITATION; BLADDER PERFORATION; CANCER CHEMOTHERAPY; CANCER SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LASER SURGERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MONOPOLAR TRANSURETHRAL RESECTION OF BLADDER TUMOR; MORTALITY; MULTIPLE CANCER; NON MUSCLE INVASIVE BLADDER CANCER; OBTURATOR NERVE REFLEX; OPERATIVE BLOOD LOSS; PATIENT SAFETY; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; TRANSURETHRAL RESECTION; TUMOR RECURRENCE; TWO MICRON CONTINUOUS WAVE LASER RESECTION; URETHRA STRICTURE;

EID: 84887379299     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513477001     Document Type: Article

References (29)

1. Zhu Z,Shen Z,Xu C.Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer.Mediators Inflamm. 2012;2012:528690-528690.
2. Agrawal MS,Agrawal M,Bansal S,et al.The safety and efficacy of different doses of bacillus Calmette-Guérin in superficial bladder transitional cell carcinoma.Urology. 2007;70:1075-1078.
3. Kirkali Z,Chan T,Manoharan M,et al.Bladder cancer: epidemiology, staging and grading, and diagnosis.Urology. 2005;66:4-34.
4. Lopez-Beltran A,Montironi R.Non-invasive urothelial neoplasms: according to the most recent WHO classification.Eur Urol. 2004;46:170-176.
5. Aldousari S,Kassouf W.Update on the management of non-muscle invasive bladder cancer.Can Urol Assoc J. 2010;4:56-64.
6. Herr HW.Surgical factors in the treatment of superficial and invasive bladder cancer.Urol Clin North Am. 2005;32:157-164.
7. Golan S,Baniel J,Lask D,et al.Transurethral resection of bladder tumour complicated by perforation requiring open surgical repair - clinical characteristics and oncological outcomes.BJU Int. 2011;107:1065-1068.
8. Xishuang S,Deyong Y,Xiangyu C,et al.Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer.J Endourol. 2010;24:69-73.
9. Khorrami MH,Javid A,Saryazdi H,et al.Transvesical blockade of the obturator nerve to prevent adductor contraction in transurethral bladder surgery.J Endourol. 2010;24:1651-1654.
10. Kramer MW,Bach T,Wolters M,et al.Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer.World J Urol. 2011;29:433-442.
11. Muraro GB,Grifoni R,Spazzafumo L.Endoscopic therapy of superficial bladder cancer in high-risk patients: Holmium laser versus transurethral resection.Surg Technol Int. 2005;14:222-226.
12. Soler-Martínez J,Vozmediano-Chicharro R,Morales-Jiménez P,et al.Holmium laser treatment for low grade, low stage, noninvasive bladder cancer with local anesthesia and early instillation of mitomycin C.J Urol. 2007;178:2337-2339.
13. Fried NM,Murray KE.High-power thulium fiber laser ablation of urinary tissues at 1.94 μm.J Endourol. 2005;19:25-31.
14. Bach T,Xia SJ,Yang Y,et al.Thulium:YAG 2 μm cw laser prostatectomy: where do we stand?.World J Urol. 2010;28:163-168.
15. Xia SJ,Zhuo J,Sun XW,et al.Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial.Eur Urol. 2008;53:382-389.
16. Zhong C,Guo S,Tang Y,et al.Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience.World J Urol. 2010;28:157-161.
17. Gravas S,Bachmann A,Reich O,et al.Critical review of lasers in benign prostatic hyperplasia (BPH).BJU Int. 2011;107:1030-1043.
18. Sauter G,Algaba F,Amin M, et alWHO Classification of Tumours of the Urinary System and Male Genital Organs. Eble JNSauter GEpstein Jl, ed. Lyon: IARCC Press; 2004:.
19. Sobin DH,Wittekind CTNM classification of malignant tumours. 6th ed. New York: Wiley-Liss, 2002, pp. 199-202.New York: Wiley-Liss; 2002:199-202.
20. Liu H,Xue S,Ruan Y,et al.2-micrometer continuous wave laser treatment for multiple non-muscle-invasive bladder cancer with intravesical instillation of epirubicin.Lasers Surg Med. 2011;43:15-20.
21. Clavien PA,Barkun J,de Oliveira ML,et al.The Clavien-Dindo classification of surgical complications: five-year experience.Ann Surg. 2009;250:187-196.
22. Kohler BA,Ward E,McCarthy B,et al.Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system.J Natl Cancer Inst. 2011;103:714-736.
23. Balbay MD,Cimentepe E,Unsal A,et al.The actual incidence of bladder perforation following transurethral bladder surgery.J Urol. 2005;174:2260-2263.
24. Nieder AM,Meinbach DS,Kim SS,et al.Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting.J Urol. 2005;174:2307-2309.
25. Sander S,Beisland HOLasers in Urologic Surgery. Smith JA, ed. St. Louis: Mosby Year Book; 1994:126-134.
26. Sylvester RJ,Brausi MA,Kirkels WJ,et al.Long-term efficacy results of EORTC Genito-Urinary Group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder.Eur Urol. 2010;57:766-773.
27. van der Meijden AP,Brausi M,Zambon V,et al.Intravesical instillation of epirubicin, bacillus Calmette-Guérin and bacillus Calmette-Guérin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer Genito-Urinary Group randomized phase III trial.J Urol. 2001;166:476-481.
28. Gao X,Ren S,Xu C,et al.Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience.BJU Int. 2008;102:1115-1118.
29. Wolters M,Kramer MW,Becker JU,et al.Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience.World J Urol. 2011;29:429-432.